other_material
confidence high
sentiment neutral
materiality 0.60
Vor Biopharma stockholders approve reverse stock split, equity plan amendment; files $119.7M ATM prospectus
Vor Biopharma Inc.
- Stockholders approved reverse stock split in range 1-for-5 to 1-for-30; board to determine ratio.
- Approved amendment to 2021 equity plan to add 25M shares and reduce annual evergreen from 5% to 4%.
- Approved issuance of common stock underlying outstanding warrants for Nasdaq Listing Rule 5635(d) compliance.
- Filed prospectus supplement to register up to $119.7M of common stock for ATM offering through Stifel.
item 5.02item 5.07item 8.01item 9.01